Atherogenesis is a chronic inflammatory process. Critical in the inflammation process is monocyte chemoattractant protein-1 (MCP-1). To locate genomic regions that affect circulating MCP-1 levels, a ...
Dallas, TX-A new potential risk marker—monocyte chemoattractant protein-1 (MCP-1)—has been shown to provide independent prognostic value in ACS patients and might also be a good therapeutic target, ...
TIMP-1 induces Fli-1 expression through miRNA-145, subsequently increasing MCP-1 expression and macrophage recruitment. MiRNA-145-enriched EVs from HSCs can transmit biological information and magnify ...
Researchers investigating the catabolic effect of parathyroid hormone (PTH) in hyperparathyroidism (HPT) have shown, for the first time, that monocyte chemoattractant protein-1 (MCP-1) is required for ...
A phase II trial of the use of 4,4’-dihydroxybenzophenone-2,4-dinitrophenyl-hydrazone (A-007) topical gel in the treatment of high-grade squamous intraepithelial lesions (HSIL) of the cervix No ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results